{
    "2021-03-16": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：CXO、医疗服务、生物制品等板块预计Q1高增长",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "医疗服务",
                        "生物制品",
                        "Q1高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品",
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "首创证券---医药生物行业简评报告：从PEG的角度看，部分优质医药资产估值已具有吸引力【行业研究】",
                "features": {
                    "keywords": [
                        "首创证券",
                        "医药生物",
                        "PEG",
                        "优质医药资产",
                        "估值吸引力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}